Bionovo, Inc. · Emeryville, CA United States (NASDAQ: BNVI)
| 5858 Horton St., Ste. 400 | Phone: 510-601-2000 |
| Emeryville, CA | Fax: 510-601-5050 |
| 94608 | |
| United States | 
Map This Company |
Bionovo, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Women's health and cancer are top concerns for drug discovery company Bionovo. Using botanically derived pharmaceutical ingredients and traditional Chinese herbs, Bionovo is formulating and testing oral and topical drug candidates -- including its most advanced, Menerba -- designed to help reduce menopause symptoms (hot flashes, night sweats, and vaginal dryness) and kill breast cancer cells. It has therapeutic agents in both clinical and preclinical stages. Bionovo was founded by CEO Isaac Cohen and president Mary Tagliaferri, who collectively own about a quarter of the company's stock.
Bionovo, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: BNVI Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 46 |
Executives
7 executives listed for Bionovo, Inc.'s Emeryville, CA location.
| Chairman, CEO, Chief Scientific Officer, and Director | Isaac Cohen | |
|---|---|---|
| President, Chief Medical Officer, Chief Regulatory Officer, and Director | Mary Tagliaferri | |
| CFO, SVP, and Director | Thomas Chesterman |